Back to Search
DANIEL HURST, M.D.
M.D.
Neurology with Special Qualifications in Child Neurology Physician
NPI: 1205828951Individual
Specialties, Licenses & Credentials
Neurology with Special Qualifications in Child Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology with Special Qualifications in Child Neurology
Code: 2084N0402X
H0067(TX)
Research & Publications (20)
Walking with modafinil and its use in diplegic cerebral palsy: retrospective review.
PMID 16900924·J Child Neurol·2006
8-other
Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.
PMID 18841483·Clin Exp Metastasis·2009
7-preclinical
Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution.
PMID 19308666·Clin Exp Metastasis·2009
8-other
Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.
PMID 19212637·Oncol Rep·2009
7-preclinical
Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression.
PMID 19585508·Int J Cancer·2009
8-other
Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.
PMID 19070953·Cancer Lett·2009
7-preclinical
Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity.
PMID 18511157·Eur J Med Chem·2009
8-other
Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.
PMID 19332369·Bioorg Med Chem Lett·2009
7-preclinical
Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.
PMID 19190326·Cancer Res·2009
8-other
Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain.
PMID 19036582·Bioorg Med Chem Lett·2009
7-preclinical
Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.
PMID 18664570·J Biol Chem·2008
8-other
Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.
PMID 19022181·Chem Biol·2008
8-other
Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
PMID 18378447·Bioorg Med Chem Lett·2008
7-preclinical
Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy.
PMID 18462938·Bioorg Med Chem Lett·2008
7-preclinical
Does treatment with inhaled corticosteroids improve outcomes in infants with RSV infection?
PMID 18472710·J Okla State Med Assoc·2008
8-other
Efficacy of allergy immunotherapy as a treatment for patients with chronic otitis media with effusion.
PMID 18541312·Int J Pediatr Otorhinolaryngol·2008
8-other
Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis.
PMID 19047132·Cancer Res·2008
7-preclinical
Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor.
PMID 19053233·Biochemistry·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3601 4TH ST # MS 9406
LUBBOCK, TX 79430 - Phone
- (806) 743-7335
Quick Facts
- NPI
- 1205828951
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile